Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Evofem Biosciences Inc. (NASDAQ:EVFM) Announces that Phase 3 EVO100 Trial Is…
Progenity Inc. (NASDAQ:PROG) Announces Expansion Of COVID-19 RT-PCR Test In The…
TG Therapeutics Inc. (NASDAQ:TGTX) Presents Triple Combination Data At 62nd American…
Ionis Pharmaceuticals Inc. (NASDAQ:IONS) Provides Updates Of Its 2020 Achievements And…
Heron Therapeutics Inc. (NASDAQ:HRTX) Resubmits HTC-011 New Drug Application To The…
Finance
Bitcoin Stocks for the Win (SQ, RIOT, ISWH, HVBTF)
The Contrarian Opportunity in Sports Stocks (CHDN, DKNG, BTDG, DKS)
Menlo Therapeutics Inc (NASDAQ:MNLO) Reports Positive Data From Phase 2 Clinical…
OSI Systems, Inc. (NASDAQ:OSIS) Bags $5 Million Order For The Supply…
TrialSpark Collaborates with resTORbio, Inc. (NASDAQ:TORC) and Integrates the Project Covalence…
Tech News
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Home
Tags
NASDAQ:RIGL
Tag: NASDAQ:RIGL
Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) Reports $16.3 Million In Net Product Revenue...
Ward Sport
-
November 16, 2020
0
Dave Santos Joins Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) As EVP: Posts Improved...
Matt Wade
-
August 21, 2020
0
British Journal of Haematology Publishes Post-Hoc Analysis of Tavalisse for Adults...
Matt Wade
-
August 4, 2020
0
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Launches Investigator-Sponsored Trial of Fostamatinib in Patients...
Kate Hudson
-
July 22, 2020
0
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Rolls Out TAVLESSE In Europe
Gavins Felicity
-
July 14, 2020
0
.td-post-views{ display: none !important; }
